Search Results - "Safin, Rustem"

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39) by Moore, Kathleen N, Bookman, Michael, Sehouli, Jalid, Miller, Austin, Anderson, Charles, Scambia, Giovanni, Myers, Tashanna, Taskiran, Cagatay, Robison, Katina, Mäenpää, Johanna, Willmott, Lyndsay, Colombo, Nicoletta, Thomes-Pepin, Jessica, Liontos, Michalis, Gold, Michael A, Garcia, Yolanda, Sharma, Sudarshan K, Darus, Christopher J, Aghajanian, Carol, Okamoto, Aikou, Wu, Xiaohua, Safin, Rustem, Wu, Fan, Molinero, Luciana, Maiya, Vidya, Khor, Victor K, Lin, Yvonne G, Pignata, Sandro

“…To evaluate the addition of the humanized monoclonal antiprogrammed death ligand-1 (PD-L1) antibody, atezolizumab, to platinum-based chemotherapy and…”
Get full text

Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study by Choynzonov, Evgeny L., Fedenko, Alexander A., Falaleeva, Natalia A., Andreeva, Tatiana V., Afanas'ev, Sergei G., Bakaev, Zelimkhan A., Valiev, Danila I., Volkov, Aleksandr A., Kolomiets, Larisa A., Krashikhina, Tatiana V., Miller, Sergei V., Mikhaliuk, Viktoriia V., Ogloblin, Andrei N., Orlova, Svetlana A., Pataliak, Stanislav V., Pokataev, Ilya A., Popova, Nataliia O., Rebrina, Olesia V., Safin, Rustem N., Stradaeva, Irina Iu, Trefilova, Iuliia V., Usol'tseva, Inessa S., Usynin, Evgenii A., Sharov, Sergey V., Iukal'chuk, Denis Iu, Iasieva, Aishat R.

“…Background. Post-registration observational studies with switching therapy from the original drug to a biosimilar for non-medical indications allow us to…”
Get full text

Dual Diagnosis: Unraveling Ankylosing Spondylitis in a Cancer Patient by Galimova, Liana, Safin, Rustem

Get full text

Incidence of severe and febrile neutropenia in cancer patients treated with myelosuppressive chemotherapy in real clinical oncology practice: Preliminary results from the FLAME study by Snegovoy, Anton, Kononenko, Inessa, Chernova, Alexandra, Shepel, Artem, Kaleikina, Liliya, Shalina, Anna, Sharov, Sergey, Pavlova, Elena, Goldshmidt, Petr, Dergunov, Alexander, Safin, Rustem, Pimonova, Irina, Yukalchuk, Denis, Soroka, Svetlana, Mikhaluk, Viktorya, Vladimirova, Liubov Yu, Yavorskaya, Marina, Starostina, Tatiyana, Tkachenko, Svetlana, Sorokina, Irina

“…e18740 Background: Febrile neutropenia (FN) is a life-threatening complication of myelosuppressive chemotherapy (CT). It can lead to infections, subsequent…”
Get full text

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study by Martín, Miguel, Lim, Elgene, Chavez-MacGregor, Mariana, Bardia, Aditya, Wu, Jiong, Zhang, Qingyuan, Nowecki, Zbigniew, Cruz, Felipe Melo, Safin, Rustem, Kim, Sung-Bae, Schem, Christian, Montero, Alberto J, Khan, Sarah, Bandyopadhyay, Reeti, Moore, Heather M, Shivhare, Mahesh, Patre, Monika, Martinalbo, Jorge, Roncoroni, Laura, Pérez-Moreno, Pablo Diego, Sohn, Joohyuk

“…To compare giredestrant and physician's choice of endocrine monotherapy (PCET) for estrogen receptor-positive, HER2-negative, advanced breast cancer (BC) in…”
Get full text

Response to Brentuximab Vedotin and Quality of Life in Patients with Relapsed/Refractory Hodgkin Lymphoma (RR HL) in the Real World Setting by Ionova, Tatyana, Afanasiev, Boris, Andrievskih, Maria, Amdiev, Alim, Baryakh, Elena A., Chang, Viktor, Husainova, Gulnara, Ivanov, Vladimir, Kaplanov, Kamil D, Kaverina, Oksana, Klitochenko, Tatiana, Kurakin, Vyacheslav, Larionova, Olga, Lazareva, Darya, Lepik, Kirill, Lysenko, Irina, Mikhailova, Nataliia, Minullina, Raisa, Mironov, Oleg, Misyurina, Elena, Mochkin, Nikita, Nikitina, Tatiana, Osipov, Iurii, Petrova, Tatiana, Porfirieva, Natalia, Rykavitcin, Oleg, Safin, Rustem, Shelekhova, Tatiana, Sherstnev, Dmitrij, Simashova, Polina, Smirnova, Elena, Trenina, Natalia, Vasiliev, Evgeniy V., Volkov, Mikhail, Volodicheva, Elena

“…There is a continued unmet medical need in pts with relapsed/refractory Hodgkin's lymphoma (RR HL). Curing HL pts who have refractory disease after salvage…”
Get full text